Article Details
Retrieved on: 2021-12-16 15:55:12
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Xevudy, developed by GSK with US firm Vir Biotechnology, is the third drug backed by the EMA that uses "monoclonal antibodies", which are proteins ...
Article found on: www.ndtv.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here